GoAI
Get started
Precision System Science Co., Ltd. logo

Precision System Science Co., Ltd.

7707.T

JPXHealthcareMedical - Diagnostics & Research

Open in GoAI

Latest quote

¥225

+¥11.00 · +5.14%

Aug 24, 3:30 PM JST

7707.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

Precision System Science Co., Ltd. (PSS), along with its subsidiaries, specializes in the development, production, and global distribution of automated and physicochemical instruments, software, and various related goods, serving both the Japanese domestic market and international clientele. The company's product line includes essential plastic consumables designed for its automated systems, a range of reagents, and sophisticated automated systems for nucleic acid extraction and veterinary biochemical analysis. PSS also offers geneLEAD, a specialized instrument crucial for molecular diagnostics. Furthermore, the firm is actively engaged in the research, development, and practical application within the in vitro diagnostics sector, particularly focusing on genetic and protein testing. Established in 1985, Precision System Science Co., Ltd. is headquartered in Matsudo, Japan.

Industry
Medical - Diagnostics & Research
Sector
Healthcare
Headquarters
JP
CEO
Yu Sugiyama
Listed since
Mar 21, 2002
Employees
151

Market position

Day range

Current ¥225

52-week range

Current ¥225

Open
¥216
Previous close
¥214
Volume
320.2K
0.93× average
Average volume
345.2K
Average daily volume
Market cap
6.18B JPY
Beta
0.66
Market reference 1
50-day average
¥202.98
+10.85% above average
200-day average
¥213.49
+5.39% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
4.97B JPY
P/E (TTM)
15.61×
P/B (TTM)
1.51×
P/S (TTM)
1.18×
EV / EBITDA
12.15×
Earnings yield
7.44%
Free cash flow yield
-0.95%
Dividend yield
0.89%

Profitability & efficiency

Gross margin
30.36%
Operating margin
3.86%
Net margin
7.57%
Return on equity
9.65%
Return on assets
6.75%
Return on invested capital
3.94%

Financial health

Debt / equity
0.25×
Current ratio
2.79×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends40%15%-10%-34%Gross margin, FY2022: 33.45%Gross margin, FY2023: 25.57%Gross margin, FY2024: 23.88%Gross margin, FY2025: 29.43%Gross margin, FY2026: 30.36%Operating margin, FY2022: 2.05%Operating margin, FY2023: -21.08%Operating margin, FY2024: -24.03%Operating margin, FY2025: -2.59%Operating margin, FY2026: 3.86%Net margin, FY2022: 0.61%Net margin, FY2023: -25.09%Net margin, FY2024: -28.18%Net margin, FY2025: -5.39%Net margin, FY2026: 7.57%FY2022FY2023FY2024FY2025FY2026
Gross margin FY2022 33.45%. Gross margin FY2023 25.57%. Gross margin FY2024 23.88%. Gross margin FY2025 29.43%. Gross margin FY2026 30.36%. Operating margin FY2022 2.05%. Operating margin FY2023 -21.08%. Operating margin FY2024 -24.03%. Operating margin FY2025 -2.59%. Operating margin FY2026 3.86%. Net margin FY2022 0.61%. Net margin FY2023 -25.09%. Net margin FY2024 -28.18%. Net margin FY2025 -5.39%. Net margin FY2026 7.57%.

Income trends

Revenue

5.22B JPY+11.17%

Operating income

201.31M JPY+322.8M JPY

Net income

394.87M JPY+647.97M JPY
Income trends across reported periods8.31B JPY4.81B JPY1.3B JPY−2.2B JPYRevenue, FY2022: 7.43B JPYRevenue, FY2023: 5.28B JPYRevenue, FY2024: 3.98B JPYRevenue, FY2025: 4.69B JPYRevenue, FY2026: 5.22B JPYOperating income, FY2022: 152.38M JPYOperating income, FY2023: −1.11B JPYOperating income, FY2024: −956.25M JPYOperating income, FY2025: −121.49M JPYOperating income, FY2026: 201.31M JPYNet income, FY2022: 45.34M JPYNet income, FY2023: −1.32B JPYNet income, FY2024: −1.12B JPYNet income, FY2025: −253.1M JPYNet income, FY2026: 394.87M JPYFY2022FY2023FY2024FY2025FY2026
Revenue FY2022 7.43B JPY. Revenue FY2023 5.28B JPY. Revenue FY2024 3.98B JPY. Revenue FY2025 4.69B JPY. Revenue FY2026 5.22B JPY. Operating income FY2022 152.38M JPY. Operating income FY2023 −1.11B JPY. Operating income FY2024 −956.25M JPY. Operating income FY2025 −121.49M JPY. Operating income FY2026 201.31M JPY. Net income FY2022 45.34M JPY. Net income FY2023 −1.32B JPY. Net income FY2024 −1.12B JPY. Net income FY2025 −253.1M JPY. Net income FY2026 394.87M JPY.
Metric (JPY)FY2026FY2025FY2024FY2023FY2022
Revenue5.22B JPY4.69B JPY3.98B JPY5.28B JPY7.43B JPY
Cost of goods sold3.63B JPY3.31B JPY3.03B JPY3.93B JPY4.95B JPY
Gross profit1.58B JPY1.38B JPY950.38M JPY1.35B JPY2.49B JPY
Research and development—128.9M JPY216M JPY375M JPY385M JPY
Selling, general, and administrative1.38B JPY1.5B JPY1.69B JPY2.09B JPY1.95B JPY
Operating expenses1.38B JPY1.5B JPY1.91B JPY2.46B JPY2.33B JPY
Interest income5.51M JPY2.81M JPY1.55M JPY2.3M JPY36K JPY
Interest expense16.79M JPY20.54M JPY31.57M JPY40.62M JPY38.13M JPY
Depreciation and amortization207.74M JPY238.11M JPY409.08M JPY641.23M JPY534.77M JPY
Operating income201.31M JPY−121.49M JPY−956.25M JPY−1.11B JPY152.38M JPY
Net income394.87M JPY−253.1M JPY−1.12B JPY−1.32B JPY45.34M JPY

Company facts updated Aug 24, 2026.

Earnings

Latest fiscal-year EPS
14.42
FY2026
Latest fiscal-year revenue
5.22B JPY
FY2026 · +11.17% year over year

Annual EPS trend

Reported history and fiscal-year consensus

ReportedConsensus forecast
Annual EPS trend20.65-4.29-29.23-54.17FY22FY23FY24FY25FY26

Annual revenue trend

Reported history and fiscal-year consensus

ReportedConsensus forecast
Annual revenue trend7.78B6.4B5.02B3.63BFY22FY23FY24FY25FY26

Corporate actions

Annual dividends per share

Cash distributions grouped by calendar year; partial years are marked.

¥5.00

2021 complete year-33.3% since 2010

2026 partial: ¥2.00

* Partial calendar year in the available dividend history.

Corporate action history

DividendUpcoming

Ex-dividend Jun 29, 2027

¥3.00

Annual

Record Jun 30, 2027 · Payment Jun 29, 2027

Dividend

Ex-dividend Jun 29, 2026

¥2.00

Irregular

Record Jun 30, 2026 · Payment Sep 28, 2026

Dividend

Ex-dividend Jun 29, 2021

¥5.00

Special

Record Jun 30, 2021 · Payment Sep 29, 2021

Dividend

Ex-dividend Jun 26, 2014

¥7.50

Annual

Dividend

Ex-dividend Jun 26, 2013

¥2,300

Annual

Dividend

Ex-dividend Jun 28, 2011

¥36,000

Annual

7707.T peers

Chugai Pharmaceutical Co., Ltd. logo

4519.T

Chugai Pharmaceutical Co., Ltd.

¥6,987

-0.34%

Takeda Pharmaceutical Company Limited logo

4502.T

Takeda Pharmaceutical Company Limited

¥5,797

+0.57%

HOYA Corporation logo

7741.T

HOYA Corporation

¥24,895

0.00%

Otsuka Holdings Co., Ltd. logo

4578.T

Otsuka Holdings Co., Ltd.

¥12,210

+0.12%

Daiichi Sankyo Company, Limited logo

4568.T

Daiichi Sankyo Company, Limited

¥2,858

+0.86%

Astellas Pharma Inc. logo

4503.T

Astellas Pharma Inc.

¥2,406.5

+0.82%

Continue in GoAI

Research 7707.T

research.disclaimer